ShanXi C&Y Pharmaceutical Group Co.,LTD. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 792.42 million compared to CNY 824.84 million a year ago. Revenue was CNY 799.31 million compared to CNY 829 million a year ago.

Net income was CNY 25.2 million compared to net loss of CNY 118.52 million a year ago. Basic earnings per share from continuing operations was CNY 0.1043 compared to basic loss per share from continuing operations of CNY 0.4999 a year ago. Diluted earnings per share from continuing operations was CNY 0.1043 compared to diluted loss per share from continuing operations of CNY 0.4999 a year ago.